141 related articles for article (PubMed ID: 38557441)
1. Galectin-1 overexpression induces normal fibroblasts translate into cancer-associated fibroblasts and attenuates the sensitivity of anlotinib in lung cancer.
Zhang L; Chen W; Li X; Wang G; Xing F; Zhu X
Cell Adh Migr; 2024 Dec; 18(1):1-11. PubMed ID: 38557441
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.
Tang D; Gao J; Wang S; Ye N; Chong Y; Huang Y; Wang J; Li B; Yin W; Wang D
Tumour Biol; 2016 Feb; 37(2):1889-99. PubMed ID: 26323258
[TBL] [Abstract][Full Text] [Related]
3. Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells.
Liang L; Hui K; Hu C; Wen Y; Yang S; Zhu P; Wang L; Xia Y; Qiao Y; Sun W; Fei J; Chen T; Zhao F; Yang B; Jiang X
J Exp Clin Cancer Res; 2019 Feb; 38(1):71. PubMed ID: 30755242
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of TGF-β1 and SDF-1 in cervical cancer-associated fibroblasts promotes cell growth, invasion and migration.
Xiao L; Zhu H; Shu J; Gong D; Zheng D; Gao J
Arch Gynecol Obstet; 2022 Jan; 305(1):179-192. PubMed ID: 34196798
[TBL] [Abstract][Full Text] [Related]
5. Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1.
He XJ; Tao HQ; Hu ZM; Ma YY; Xu J; Wang HJ; Xia YJ; Li L; Fei BY; Li YQ; Chen JZ
Cancer Sci; 2014 Nov; 105(11):1402-10. PubMed ID: 25230369
[TBL] [Abstract][Full Text] [Related]
6. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts.
Masuda T; Nakashima T; Namba M; Yamaguchi K; Sakamoto S; Horimasu Y; Miyamoto S; Iwamoto H; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
J Cell Mol Med; 2019 Apr; 23(4):2984-2994. PubMed ID: 30734495
[TBL] [Abstract][Full Text] [Related]
8. NEAT 1 knockdown enhances the sensitivity of human non-small-cell lung cancer cells to anlotinib.
Gu G; Hu C; Hui K; Chen T; Zhang H; Jiang X
Aging (Albany NY); 2021 May; 13(10):13941-13953. PubMed ID: 33982669
[TBL] [Abstract][Full Text] [Related]
9. Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-β1-induced epithelial-mesenchymal transition in gastric cancer.
You X; Wu J; Zhao X; Jiang X; Tao W; Chen Z; Huang C; Zheng T; Shen X
Aging (Albany NY); 2021 Jul; 13(14):18464-18481. PubMed ID: 34260413
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-6077 enhances the sensitivity of patients-derived lung adenocarcinoma cells to anlotinib by repressing the activation of glucose transporter 1 pathway.
Ma DB; Qin MM; Shi L; Ding XM
Cell Signal; 2019 Dec; 64():109391. PubMed ID: 31421224
[TBL] [Abstract][Full Text] [Related]
11. Anlotinib exerts anti-cancer efficiency on lung cancer stem cells in vitro and in vivo through reducing NF-κB activity.
Li Z; Tian J; Du L; Gao Y; Wang Y; You F; Wang L
J Cell Mol Med; 2021 Jun; 25(12):5547-5559. PubMed ID: 33955683
[TBL] [Abstract][Full Text] [Related]
12. Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer without harboring EGFR T790M mutation.
Lian Z; Du W; Zhang Y; Fu Y; Liu T; Wang A; Cai T; Zhu J; Zeng Y; Liu Z; Huang JA
Thorac Cancer; 2020 Jul; 11(7):1934-1943. PubMed ID: 32433828
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts derived extracellular vesicles promote angiogenesis of colorectal adenocarcinoma cells through miR-135b-5p/FOXO1 axis.
Dai X; Xie Y; Dong M
Cancer Biol Ther; 2022 Dec; 23(1):76-88. PubMed ID: 35100092
[TBL] [Abstract][Full Text] [Related]
14. Reversal of galectin-1 gene silencing on resistance to cisplatin in human lung adenocarcinoma A549 cells.
Zhang L; Liu X; Tang Z; Li X; Wang G
Biomed Pharmacother; 2016 Oct; 83():265-270. PubMed ID: 27392028
[TBL] [Abstract][Full Text] [Related]
15. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.
Kim SH; Choe C; Shin YS; Jeon MJ; Choi SJ; Lee J; Bae GY; Cha HJ; Kim J
Anticancer Res; 2013 May; 33(5):2001-9. PubMed ID: 23645749
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer.
Zheng L; Xu C; Guan Z; Su X; Xu Z; Cao J; Teng L
Am J Transl Res; 2016; 8(4):1641-58. PubMed ID: 27186290
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironment.
Shen Z; Qin X; Yan M; Li R; Chen G; Zhang J; Chen W
Oncotarget; 2017 Jan; 8(1):1290-1303. PubMed ID: 27901488
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer-derived galectin-1 contributes to cancer associated fibroblast-mediated cancer progression and immune suppression through TDO2/kynurenine axis.
Hsu YL; Hung JY; Chiang SY; Jian SF; Wu CY; Lin YS; Tsai YM; Chou SH; Tsai MJ; Kuo PL
Oncotarget; 2016 May; 7(19):27584-98. PubMed ID: 27050278
[TBL] [Abstract][Full Text] [Related]
19. β-Sitosterol attenuates anlotinib resistance in non-small cell lung cancer cells by inhibiting miR-181a-3p/SHQ1 signaling.
Wang LH; Sun YH; Liu H; Yang X; Wen Z; Tian XF
Chem Biol Drug Des; 2024 Mar; 103(3):e14493. PubMed ID: 38439529
[TBL] [Abstract][Full Text] [Related]
20. Induction of galectin-1 by TGF-β1 accelerates fibrosis through enhancing nuclear retention of Smad2.
Lim MJ; Ahn J; Yi JY; Kim MH; Son AR; Lee SL; Lim DS; Kim SS; Kang MA; Han Y; Song JY
Exp Cell Res; 2014 Aug; 326(1):125-35. PubMed ID: 24928277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]